Skip to main content
. 2020 Mar 26;12(4):785. doi: 10.3390/cancers12040785

Figure 2.

Figure 2

Detection of three EGFR mutations in plasma samples. (A) PPA of the two tests in plasma, stratified by disease stage. PPA is calculated as percentage of mutations detected in tumor that are also detected in plasma. (B) Precision of the two tests in plasma for all disease stages. Precision is calculated as the percentage of mutations detected in plasma that are also detected in tumor. PPA, positive percentage agreement; EGFR, epidermal growth factor receptor.